Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
Clinical trial NCT01405196 · COMPLETED
Trial details
- NCT number
- NCT01405196
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2014-03-01
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.